Announcements Trials
Browse Landscape

Status

Completed 17Active not recruiting 6Recruiting 4Unknown 2No longer available 2Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 2

Conditions

Gastrointestinal Stromal Tumors 2

Interventions

tazemetostat 2regorafenib 2Trabectedin 2omburtamab I-131 1nirogacestat 1ganitumab 1fludarabine phosphate 1avapritinib 1Whole-Body Irradiation 1Tacrolimus 1TH 302 1Mycophenolic Acid 1Imatinib Mesylate 1Everolimus 1DOXO-EMCH 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × regorafenib × Sarcoma × Clear all
NCT01689376 2016-08-16

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Bayer

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01646593 2014-12-15

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Bayer

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡